The fundamental objectives of this proposal are two-fold: 1) to evaluate risk factors for and sequelae of thyroid functional disease in patients with impaired renal function and 2) to promote development towards a career as an independent clinical investigator. Both chronic kidney disease and thyroid dysfunction are common in the US population, and both are known to adversely affect cardiovascular health in survival. Prior evidence indicates that there is an increased prevalence of thyroid disease in patients with chronic kidney disease and end-stage renal disease, which occurs in proportion to the degree of renal injury.
Aim 1 will explore one potential mechanistic link for this association, namely whether thyroid disease is promoted by exposure to iodinated contrast media in the setting of decreased renal excretory capacity. There is uncertainty as to whether, and in which direction, hyper- and hypothyroidism may influence mortality in the end-stage renal disease population based on limited data, and there has been no study of the associations of hyper- and hypothyroidism and mortality among patients with pre-end-stage chronic kidney disease.
Aim 2 will explore whether the association between thyroid dysfunction and cardiovascular and all-cause mortality is magnified in the context of renal dysfunction.
Aim 1 will be explored using a retrospective cohort of patients cared for by Harvard Vanguard Medical Associates, a large, community based multispecialty group that services a diverse patient population and provides comprehensive capture of co-morbidity, procedural, and medication data.
Aim 2 will be explored using the Third National Health and Nutrition Examination Survey data which provides detailed cross-sectional data and longitudinal mortality follow-up on a representative sample of the US population. This study will provide valuable data that both informs clinical practice and guides future research. Moreover, the proposed study will provide additional experience in applying tenants of study design, data analysis, statistical programming, and scientific writing, in paralle with didactic training in the Master of Science in Epidemiology program at the Harvard School of Public Health. The combination of formal didactics, experience in the conduct of research, opportunity to create a publication track record, and mentorship provided by the sponsor and collaborators will promote development towards becoming an independent investigator. Furthermore, this research endeavor will provide the practical experience and data necessary for development and submission of a Mentored Career Development Award application, which will be formulated toward the end of the period under award.

Public Health Relevance

Both chronic kidney disease and thyroid dysfunction are common in the US population, and both are known to adversely affect cardiovascular health in survival. Prior evidence indicates that there is an increased prevalence of thyroid disease among patients with chronic kidney disease and end-stage renal disease. This study will explore 1) whether thyroid disease is promoted by exposure to iodinated contrast media in the setting of impaired renal function and 2) whether the cardiovascular and all-cause mortality of thyroid dysfunction are magnified in the context of impaired renal function.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
1F32DK093201-01A1
Application #
8395786
Study Section
Special Emphasis Panel (ZDK1-GRB-G (M1))
Program Officer
Rankin, Tracy L
Project Start
2012-07-01
Project End
2013-06-30
Budget Start
2012-07-01
Budget End
2013-06-30
Support Year
1
Fiscal Year
2012
Total Cost
$64,730
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
030811269
City
Boston
State
MA
Country
United States
Zip Code
02115
Rhee, Connie M; Brent, Gregory A; Kovesdy, Csaba P et al. (2015) Thyroid functional disease: an under-recognized cardiovascular risk factor in kidney disease patients. Nephrol Dial Transplant 30:724-37
Park, Jongha; Rhee, Connie M; Lau, Wei Ling et al. (2014) Clinical uses of 1-alpha-hydroxy-ergocalciferol. Curr Vasc Pharmacol 12:306-12
Rhee, Connie M; Lertdumrongluk, Paungpaga; Streja, Elani et al. (2014) Impact of age, race and ethnicity on dialysis patient survival and kidney transplantation disparities. Am J Nephrol 39:183-94
Rhee, Connie M; Molnar, Miklos Z; Lau, Wei Ling et al. (2014) Comparative mortality-predictability using alkaline phosphatase and parathyroid hormone in patients on peritoneal dialysis and hemodialysis. Perit Dial Int 34:732-48
Lertdumrongluk, Paungpaga; Lau, Wei Ling; Park, Jongha et al. (2013) Impact of age on survival predictability of bone turnover markers in hemodialysis patients. Nephrol Dial Transplant 28:2535-45
Park, Jongha; Rhee, Connie M; Sim, John J et al. (2013) A comparative effectiveness research study of the change in blood pressure during hemodialysis treatment and survival. Kidney Int 84:795-802
Hoshino, Junichi; Mehrotra, Rajnish; Rhee, Connie M et al. (2013) Using hemoglobin A1c to derive mean blood glucose in peritoneal dialysis patients. Am J Nephrol 37:413-20
Rhee, Connie M; Unruh, Mark; Chen, Jing et al. (2013) Infrequent dialysis: a new paradigm for hemodialysis initiation. Semin Dial 26:720-7
Rhee, Connie M; Curhan, Gary C; Alexander, Erik K et al. (2013) Subclinical hypothyroidism and survival: the effects of heart failure and race. J Clin Endocrinol Metab 98:2326-36
Harley, Kevin T; Streja, Elani; Rhee, Connie M et al. (2013) Nephrologist caseload and hemodialysis patient survival in an urban cohort. J Am Soc Nephrol 24:1678-87

Showing the most recent 10 out of 13 publications